PDF-22 May 2013EMA//2013Committee for Medicinal Products for Human Use (CH
Author : yoshiko-marsland | Published Date : 2016-05-21
Adoption by CHMP27 June 2013 Keywords Surface coating Nanomedicines non clinical 7 Westferry Circus Reflection paper on urface coatings general issues for consideration
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "22 May 2013EMA//2013Committee for Medici..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
22 May 2013EMA//2013Committee for Medicinal Products for Human Use (CH: Transcript
Adoption by CHMP27 June 2013 Keywords Surface coating Nanomedicines non clinical 7 Westferry Circus Reflection paper on urface coatings general issues for consideration regarding parenteral admi. europaeu Website wwwemaeuropaeu European Medicines Agency 2014 Reproduction is authorised provided the source is ac knowledged Guideline on similar biological medicinal products containing biotechnology derived proteins as active substance quality Cannabis contains a number of active substances like dronabinol THC and cannabidiol CBD THC is mainly responsible for the e64256ects of cannabis but others like CBD may also in64258uence the e64256ectiveness of the drug The chemical composition of 7 Westferry Circus Canary Wharf London E14 4HB United KingdomAn agency of the European Union Telephone+44 (0)20 7418 8400 The sponsor has provided sufficient information to show that immortalised hu Initial assessement March 2007 Adoption by Committee on Herbal Medicinal Products (HMPC) for release for consultation 8 March 15 June 2007 Rediscussion in MLWP September 2007 Adoption by HMPC Monog V-JSAT2-May-15SUN3-May-15MON4-May-15V-BTUE5-May-15V-L/BV-JWED6-May-15THU7-May-15FRI8-May-15V-L/BV-JSAT9-May-15SUN10-May-15MON11-May-15V-BTUE12-May-15V-L/BV-J13-May-15THU14-May-15FRI15-May-15V-L/BV-JSA P. lants . Garden . P. roject. “. H. ome garden. ” for . Primary health care . well using. natural resource and human resource. T. raditional medicine (TM) public . service. isn’t existing in Cambodia despite of existing abundant . Abstract — A study of undertaken in Cibeo society, by valuation Local User’s Value Index (LUVI). The purpose of this study reveal the value of the most important medicinal plants based on per GS1 2017 GS1 2017The views and opinions presented here represent those of the speaker and should not be considered to represent advice or guidance on behalf of the US Food and Drug Administration GS Noureddine Chaachouay. *. . Corresponding author: . Ait. . Laasri. . Massaghra. El . Kansera. , 15000 . Khemisset. , Morocco.. Tel: +212677488621 Email: nour.chay@gmail.com. Nutrition, health and environment Laboratory, Department of Biology, Faculty of Sciences, Ibn . Assist.Prof.Dr.Widad. . Jumaa. . Hamid. Medicinal plants. , . medicinal herbs. , or simply . herbs. have been identified and used from prehistoric times. Plants make many chemical compounds for biological functions, including . Eleni Antoniou. Senior Policy Officer. Thalassaemia. International Federation. TIF European Thalassaemia & Sickle Cell Disease Symposium. Session 12: Achieving Healthcare Reforms through Patient . Learning Objectives. Summarise regulatory changes and other issues that need to be considered for the legal use and supply of medicinal cannabis . Discuss the Commonwealth and state specific requirements to prescribe and dispense medicinal cannabis in Australia. Consequences . on interoperability. Jean-Noël . Nikiema & . Olivier Bodenreider. National Institutes of Health, Bethesda, Maryland, USA. SNOMED CT Expo. Kual. a Lumpur. , Malaysia. November 1, 2019. world. Tania Ramírez. Map of countries in which medicinal cannabis is available. Medicinal cannabis . regulated. Argentina, Australia, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, Finland, France, Germany, Greece, Israel, Italy,...
Download Document
Here is the link to download the presentation.
"22 May 2013EMA//2013Committee for Medicinal Products for Human Use (CH"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents